1Diabetes UK. Obesity increases diabetes risk up to 80 times[N/OL], http:// www.diabetes.org.uk/About_us/News_Landing Page/2005-03-18.
2Yao L, Herlea-Pana O, Heuser-Baker J, et al. Roles of the chemokine system in development of obesity, insulin resistance,and cardiovascular disease[J]. J Immunol Res, 2014: 181450.
3Lim S. Ectopic fat assessment focusing on cardiometabolic and renal risk[J].Endocrinol Metab(Seoul), 2014, 29(1): 1-4.
4Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease[J]. Int J Mol Sci, 2014, 15(4): 6184-6223.
5S~'ohle A, Worm N. Healthy obesity? Why the adiposity paradox is only seemingly paradox[J]. Med Monatsschr Pharm, 2014, 37(2): 54-64.
6McL aughlin T, Lamendola C, Liu A, et al. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity[J]. J Clin Endocrinol Metab, 2011, 96(11): E1756- E1760.
7Boyko EJ, Fujimoto WY, Leonetti DL, et al. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans[l]. Diabetes Care, 2000, 23(4): 465-471.
8Preis SIL Massaro JM, Robins S.I, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study[J]. Obesity(Silver Spring), 2010, 18 ( 11 ): 2191-2198.
9Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults[J]. JAMA, 2012, 308(11): 1150-1159.
10Li S, Xiao J, Ji L, et al. BMI and waist circumference are associated with impaired glucose metabolism and type 2 diabetes in normal weight Chinese adults[J]. J Diabetes Complications, 2014, 28(4): 470-476.
